Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during PCI ...

NEW ORLEANS — Addressing a persistent controversy, a tightly blinded trial has confirmed a significant reduction of angina for patients with a chronic total occlusion (CTO) when treated with a ...

Please provide your email address to receive an email when new articles are posted on . PCI successfully reduced angina symptoms and frequency in select patients with chronic total occlusion.

Routine use of the Impella CP microaxial flow pump did not improve outcomes and may have contributed to deaths among patients undergoing high-risk percutaneous coronary intervention (PCI), according ...

Framework has introduced the Laptop 13 Pro, marking the first major chassis redesign since the original Framework Laptop 13 ...

That has made repurposing your existing hardware more important than ever, which is where a recently discovered method for ...

NEW ORLEANS, LA—The Impella CP percutaneous left ventricular assist device (pLVAD) does not reduce major adverse events when used in the setting of high-risk PCI, according to the CHIP-BCIS3 trial.

But so far most OCuLink products designed for consumers have been limited to 4 lanes of PCIe 4.0 The Framework Laptop 16’s ...

In the catheterization laboratory, the most consequential decisions are frequently not about whether to treat, but rather about how far to extend treatment. Nowhere is that tension more apparent than ...

China is exploring new approaches to reduce its reliance on Nvidia’s CUDA software, which plays a key role in the company’s ...